NEW YORK (GenomeWeb News) – Baylor College of Medicine scientists plan to use two new Department of Defense grants to study genomic changes involved in breast cancer tumor formation and therapeutic targets based on those alterations.

The roughly $780,000 in total funding to two researchers at BCM's Lester and Sue Smith Breast Center, Assistant Professor Xiaosong Wang and Associate Professor Rachel Schiff, was awarded under DoD's Breast Cancer Research Program.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

In Nature this week: paternal age associated with de novo mutations in children, and more.

Nature News writes that researchers are still wrangling over the role of the p-value.